SS&C Technologies Holdings (SSNC US)
SSNC US$80.48
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 80.48
- Change
- ▲ 0.26 (0.32)
- Bid / Ask
- 80.46 - 87.17
- Volume
- 588,353
- Turnover
- 12,100,675
- Open
- 79.68
- Day Range
- 79.59 - 80.74
- VWAP
- 80.16
- Prev Close
- 80.22
- Last Trade
- 28/10 4:00pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Technology
- Shares Issued
- 234,654,996
- NTA/Share
- -28.14
- Last Dividend
- 0.30
- Dividend Ex Date
- 1 SEP 2026
- Dividend Pay Date
- 15 SEP 2026
Current (USD) · FY2025
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 6,272.20
- EBITDA
- 2,104.90
- Profit
- 796.90
- Earnings Per Share (EPS)
- 3.15
- Dividend Per Share (DPS)
- 1.04
- Yield %
- 1.38
- Market Cap
- 18,885.03
- Price to Earnings Ratio (P/E)
- 23.13
Estimates (USD) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 7,010.52
- EBITDA
- 2,534.00
- Profit
- 1,821.07
- Earnings Per Share (EPS)
- 7.50
- Dividend Per Share (DPS)
- 1.19
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- None
- Financial Health
- Moderate
- Uncertainty
- Low
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 91.40 Fair value 96.95 One-star price 102.83
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 96.95
- Price / Fair Value
- 0.83
- Valuation
- Undervalued
- Uncertainty
- Low
Morningstar Quantitative Rating as of 28 OCT 2026. The slider runs from the five-star price (91.40) to the one-star price (102.83).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 80.48 |
| Price - 12 month high | 89.93 |
| Price - 12 month low | 61.42 |
| Pricing date | 27 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 1.73 |
| Market capitalization | 18,887.38 |
| 12 Month High price date | 29 DEC 2025 |
| 12 Month Low price date | 30 JUN 2026 |
| Volume - avg. trading volume for the last 3 months | 1.61 |
| Price - 1 Day % Change | 0.32% |
| Price - 13 week price percent change | 3.31% |
| Price - 26 week price percent change | 16.47% |
| Price - 5 Day % Change | -7.59% |
| Price - 52 week price percent change | -5.73% |
| Price - YTD price percent change | -9.06% |
| Price % Change Month To Date | 3.18% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | 3.150 |
| EPS excluding extraordinary items - trailing 12 month | 3.470 |
| EPS Normalized - most recent fiscal year | 6.140 |
| Revenue/share - most recent fiscal year | 24.782 |
| Revenue/share - trailing 12 month | — |
| Book value per share - most recent fiscal year | 28.532 |
| Book value per share - most recent quarter | 28.306 |
| Book value (tangible) per share - most recent fiscal year | -28.138 |
| Book value (tangible) per share - most recent quarter | -30.236 |
| Cash per share - most recent fiscal year | 1.914 |
| Cash per share - most recent quarter | 1.853 |
| Cash Flow per share - most recent fiscal year | 7.198 |
| Cash Flow per share - trailing 12 month | 7.903 |
| Dividend per share - most recent fiscal year | 1.040 |
| Dividends per share - trailing 12 month | 1.110 |
| EBITD per share - trailing 12 month | — |
| EPS Basic excluding extraordinary items - most recent fiscal year | 3.260 |
| EPS Basic excluding extraordinary items - trailing 12 month | 3.570 |
| EPS including extraordinary items - most recent fiscal year | 3.260 |
| EPS including extraordinary items - trailing 12 month | 3.580 |
| Free Cash Flow per share - trailing 12 month | 6.647 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 23.20 |
| P/E Normalized, most recent fiscal year | 11.63 |
| Price to sales - most recent fiscal year | 2.96 |
| Price to Tangible Book - most fiscal year | — |
| Price to Free Cash Flow per Share - most recent fiscal year | 12.23 |
| Price to Cash Flow per share - trailing 12 month | 10.29 |
| Price to Book - most recent fiscal year | 2.82 |
| P/E excluding extraordinary items high, trailing 12 months | 26.59 |
| P/E excluding extraordinary items low, trailing 12 months | 19.27 |
| Net Debt, LFI | 7,342.50 |
| Net Debt, LFY | 7,184.50 |
| Dividend Yield - 5 Year Average | 1.29% |
| Dividend Yield - indicated annual dividend divided by closing price | 1.38% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 1.38% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 1,519.20 |
| LT debt/equity - most recent fiscal year | 109.79% |
| Payout ratio - most recent fiscal year | 33.02% |
| Total debt/total equity - most recent fiscal year | 110.15% |
| LT debt/equity - most recent quarter | 111.95% |
| Total debt/total equity - most recent quarter | 115.90% |
| Free Cash Flow - trailing 12 month | 1,652.70 |
| Payout ratio - trailing 12 month | 31.03% |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 6,272.20 |
| Revenue - trailing 12 month | 6,564.30 |
| EBITD - most recent fiscal year | 2,104.90 |
| EBITD - trailing 12 month | — |
| Earnings before taxes - most recent fiscal year | 974.80 |
| Earnings before taxes - trailing 12 month | 1,091.30 |
| Net Income available to common - most recent fiscal year | 796.90 |
| Net Income available to common - trailing 12 months | 864.00 |
| Earnings before taxes Normalized - most recent fiscal year | 1,274.30 |
| Net Income Available to Common, Normalized - most recent fiscal year | — |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | — |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | 12.73% |
| Net Profit Margin % - trailing 12 month | 13.19% |
| Operating margin - 1st historical fiscal year | 22.91% |
| Operating margin - trailing 12 month | 23.61% |
| Pretax margin - trailing 12 month | 16.62% |
| Pretax margin - 1st historical fiscal year | 15.54% |
| Operating Margin - 5 year average | 22.79% |
| Pretax Margin - 5 year average | 16.69% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 22.90% |
| Free Operating Cash Flow/Revenue, TTM | — |
| Net Profit Margin - 5 year average | 12.98% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | 4.05% |
| Return on average assets - trailing 12 month | — |
| Return on average equity - most recent fiscal year | 11.72% |
| Return on average equity - trailing 12 month | — |
| Return on average assets - 5 year average | 4.12% |
| Return on average equity - 5 year average | 11.61% |
| Net Income/employee - most recent fiscal year | 27,732.64 |
| Revenue/employee - most recent fiscal year | 217,784.72 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 6.09% |
| EPS growth rate, 5 year | 6.03% |
| Growth rate% - dividend, 3 year | 9.14% |
| Revenue/share (5 yr growth) | 7.19% |
| Growth rate% - Revenue, 3 year | 5.89% |
| Growth rate% - EPS, 3 year | 8.30% |
| Book value per share growth rate, 5 year | 5.15% |
| Capital Spending growth rate, 5 year | 23.26% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | 3.80% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (USD, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | 2028 | 2029 | ||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (USD, millions)
| Period end: | DEC 21 | DEC 22 | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services. Acquisitions are a large part of SS&C's history. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C's purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C acquired robotic process automation software firm Blue Prism.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
